Wednesday, 24 May 2017

China News

  • Generon initiates phase I clinical study for F-652 in Australia

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein containing a human interleukin-22 (IL-22) dimer. The current phase I...Read more

  • Type 2 diabetes could be next epidemic in India, China

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: Despite modern science's best efforts, the most common type of diabetes, Type 2, is reaching epidemic levels across the world, especially India and China, according to market ana...Read more

  • Challenge No 1: A culture cauldron

    China |  Analysis | By Narayan Kulkarni | 0 Comment

    The countries in Asia have different languages, cultures and religion. Some of them are even a melting pot of people from different linguistic, cultural and historical backgrounds. This div...Read more

  • Aus drug delivery technology gets Chinese patent

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian drug delivery technology company Imugene has received key Chinese patent application for the company's novel drug delivery technology Linguet. The Chinese application...Read more

  • Successful Year With a Redefined Business Model

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore:  SINOPHARM Group, China Chairman: Mr Wei YulinRevenue: $31299.8 mnBusiness: R&D, manufacturing, distribution of healthcare products, value added supply chain, service provi...Read more

  • China's Zai Lab raises $100mn

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B financing from a group of investors led by Advantech Capital and included ...Read more

  • China launches nationwide inspection of vaccines

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Ahead of a huge recent vaccine scandal racket revealing China's vaccine black market in March this year, Chinese health authorities have now appointed a special investigation tea...Read more

  • 3SBio appoints Kevin Xiao Weihong as new COO

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: China based 3SBio has appointed Kevin Xiao Weihong as its new chief operating officer. "We are pleased to welcome Kevin to 3SBio where he will play a key role in providing lead...Read more

  • Breast cancer market will rise to $3.4 billion by 2021'

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The Asia-Pacific (APAC) breast cancer market is set to experience considerable expansion from $1.9 billion in 2014 to $3.4 billion by 2021, at a robust Compound Annual Growth Rat...Read more

  • Jeremy Yee quits China Cord Blood board

    China |  Influencers | By BioSpectrum Bureau | 0 Comment

    Singapore: Mr Jeremy Yee, an independent non-executive director of China Cord Blood Corporation (CCBC), a provider of cord blood collection, laboratory testing, hematopoietic stem cell proc...Read more

  • China's Jiangsu Hengrui to build a new biologics facility

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: China-based Jiangsu Hengrui Medicine recently announced plans to build a biologics manufacturing plant in Suzhou with an investment of $137 million. Hengrui, an integrated pharma...Read more

  • F&S: China, India are hotspot for cardiac imaging

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    ‎Singapore: A new study from Frost & Sullivan titled 'Global Trends in Medical Imaging-Cardiology Applications', has pointed out that there has been a shift in the adoption patter...Read more

  • It's raining expansions and JVs in China!

    China |  Analysis | By Amrita Tejasvi | 0 Comment

    Biopharma firms, which are located on the western part of the globe, are keeping a close watch on the dragon nation, with hopes that they can leverage on the potential that China has to off...Read more

  • PerkinElmer acquires Chinese diagnostics giant

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: PerkinElmer completed the acquisition of Shanghai Haoyuan Biotech, a China-based infectious disease diagnostics company. The acquisition extends PerkinElmer's capabilities into ...Read more

  • AstraZeneca continues strategic investment in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: AstraZeneca, along with MedImmune, its global biologics research and development arm, has announced a range of strategic initiatives to accelerate the delivery of innovative biol...Read more

  • Scientists make controversial H7N9 proposal

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A leading group of influenza scientists have proposed to conduct a highly controversial 'gain-of-function' bird flu research that has already generated some harsh criticism. Fur...Read more

  • Asia's lung cancer burden

    China |  Analysis | By Amrita Tejasvi | 0 Comment

    Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to oncology specialists' analysis, 85 percent of the lung cancer patien...Read more

  • Biosimilars to push growth in China, Korea, India

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The annual revenue for biopharmaceuticals has been consistently growing since 2001, accounting for 15.6 percent of the total pharmaceutical market in 2011. The global biopharmac...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls